Angélica Medina , Jacob Sussman , Natalia Sosa , Melissa Valdez , Jason R. Andrews , Julio Croda , Gladys Estigarribia Sanabria , Guillermo Sequera , Sarita Aguirre , Katharine S. Walter
{"title":"2018-2022年巴拉圭土著人口中结核病的集中:一项基于人口的回顾性研究","authors":"Angélica Medina , Jacob Sussman , Natalia Sosa , Melissa Valdez , Jason R. Andrews , Julio Croda , Gladys Estigarribia Sanabria , Guillermo Sequera , Sarita Aguirre , Katharine S. Walter","doi":"10.1016/j.lana.2025.101140","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>While over the past decade global incidence rates of tuberculosis (TB) have decreased, in Paraguay incidence has risen. A new reporting system implemented in 2018 has not previously been used to characterise trends in TB and identify areas to prioritise for the expansion of access to TB diagnostics and treatment programmes.</div></div><div><h3>Methods</h3><div>We conducted a retrospective study of all TB cases notified to the Paraguay National Program for Tuberculosis Control (NPTC) from 2018 to 2022. We quantified trends in case notifications spatially and in specific populations identified as vulnerable by the NPTC and measured trends in access to GeneXpert testing.</div></div><div><h3>Findings</h3><div>Of the 13,725 TB cases notified in Paraguay from 2018 to 2022, 2337 (17%) occurred among incarcerated individuals and 1743 (12.7%) occurred among self-identified Indigenous individuals. In 2022, the relative risk of TB was 87 and 6.39 (95% CI: 6.08–6.72) among persons deprived of liberty and Indigenous populations, compared to those who are not persons deprived of liberty and non-Indigenous populations respectively. We found significant heterogeneity in TB incidence across Paraguay’s 17 departments. While 45% of TB cases among the Indigenous population occurred in the Chaco Region, in western Paraguay, notification among the Indigenous population was highest (1127.4 per 100,000) in the Capital, including the metropolitan area.</div></div><div><h3>Interpretation</h3><div>TB cases are concentrated among Paraguay’s incarcerated and Indigenous populations, both of which have extremely high relative risk of TB. Our findings highlight the urgency of expanding access to TB diagnosis, treatment, and prevention across the country and specifically, to the populations at heightened risk of TB.</div></div><div><h3>Funding</h3><div><span><span>K01AI173385</span></span> (<span>NIH</span>, <span>NIAID</span>), <span>University of Utah</span> UROP.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"47 ","pages":"Article 101140"},"PeriodicalIF":7.0000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The concentration of tuberculosis within Paraguay’s Indigenous population, 2018–2022: a retrospective population-based study\",\"authors\":\"Angélica Medina , Jacob Sussman , Natalia Sosa , Melissa Valdez , Jason R. Andrews , Julio Croda , Gladys Estigarribia Sanabria , Guillermo Sequera , Sarita Aguirre , Katharine S. Walter\",\"doi\":\"10.1016/j.lana.2025.101140\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>While over the past decade global incidence rates of tuberculosis (TB) have decreased, in Paraguay incidence has risen. A new reporting system implemented in 2018 has not previously been used to characterise trends in TB and identify areas to prioritise for the expansion of access to TB diagnostics and treatment programmes.</div></div><div><h3>Methods</h3><div>We conducted a retrospective study of all TB cases notified to the Paraguay National Program for Tuberculosis Control (NPTC) from 2018 to 2022. We quantified trends in case notifications spatially and in specific populations identified as vulnerable by the NPTC and measured trends in access to GeneXpert testing.</div></div><div><h3>Findings</h3><div>Of the 13,725 TB cases notified in Paraguay from 2018 to 2022, 2337 (17%) occurred among incarcerated individuals and 1743 (12.7%) occurred among self-identified Indigenous individuals. In 2022, the relative risk of TB was 87 and 6.39 (95% CI: 6.08–6.72) among persons deprived of liberty and Indigenous populations, compared to those who are not persons deprived of liberty and non-Indigenous populations respectively. We found significant heterogeneity in TB incidence across Paraguay’s 17 departments. While 45% of TB cases among the Indigenous population occurred in the Chaco Region, in western Paraguay, notification among the Indigenous population was highest (1127.4 per 100,000) in the Capital, including the metropolitan area.</div></div><div><h3>Interpretation</h3><div>TB cases are concentrated among Paraguay’s incarcerated and Indigenous populations, both of which have extremely high relative risk of TB. Our findings highlight the urgency of expanding access to TB diagnosis, treatment, and prevention across the country and specifically, to the populations at heightened risk of TB.</div></div><div><h3>Funding</h3><div><span><span>K01AI173385</span></span> (<span>NIH</span>, <span>NIAID</span>), <span>University of Utah</span> UROP.</div></div>\",\"PeriodicalId\":29783,\"journal\":{\"name\":\"Lancet Regional Health-Americas\",\"volume\":\"47 \",\"pages\":\"Article 101140\"},\"PeriodicalIF\":7.0000,\"publicationDate\":\"2025-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Regional Health-Americas\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667193X25001504\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Regional Health-Americas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667193X25001504","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
The concentration of tuberculosis within Paraguay’s Indigenous population, 2018–2022: a retrospective population-based study
Background
While over the past decade global incidence rates of tuberculosis (TB) have decreased, in Paraguay incidence has risen. A new reporting system implemented in 2018 has not previously been used to characterise trends in TB and identify areas to prioritise for the expansion of access to TB diagnostics and treatment programmes.
Methods
We conducted a retrospective study of all TB cases notified to the Paraguay National Program for Tuberculosis Control (NPTC) from 2018 to 2022. We quantified trends in case notifications spatially and in specific populations identified as vulnerable by the NPTC and measured trends in access to GeneXpert testing.
Findings
Of the 13,725 TB cases notified in Paraguay from 2018 to 2022, 2337 (17%) occurred among incarcerated individuals and 1743 (12.7%) occurred among self-identified Indigenous individuals. In 2022, the relative risk of TB was 87 and 6.39 (95% CI: 6.08–6.72) among persons deprived of liberty and Indigenous populations, compared to those who are not persons deprived of liberty and non-Indigenous populations respectively. We found significant heterogeneity in TB incidence across Paraguay’s 17 departments. While 45% of TB cases among the Indigenous population occurred in the Chaco Region, in western Paraguay, notification among the Indigenous population was highest (1127.4 per 100,000) in the Capital, including the metropolitan area.
Interpretation
TB cases are concentrated among Paraguay’s incarcerated and Indigenous populations, both of which have extremely high relative risk of TB. Our findings highlight the urgency of expanding access to TB diagnosis, treatment, and prevention across the country and specifically, to the populations at heightened risk of TB.
Funding
K01AI173385 (NIH, NIAID), University of Utah UROP.
期刊介绍:
The Lancet Regional Health – Americas, an open-access journal, contributes to The Lancet's global initiative by focusing on health-care quality and access in the Americas. It aims to advance clinical practice and health policy in the region, promoting better health outcomes. The journal publishes high-quality original research advocating change or shedding light on clinical practice and health policy. It welcomes submissions on various regional health topics, including infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, emergency care, health policy, and health equity.